Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Meda
Meda
Activities:
Manufacturing
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide
CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
CPI collaborates with industry leaders to expedite drug manufacturing via digitisation
Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation
The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Mylan to acquire Meda in US$9.9bn cash and stock deal
Will create a leading pharma firm with a portfolio of branded and generic medicines and a strong portfolio of over-the-counter products
Manufacturing
DPT Laboratories acquires Meda Pharmaceuticals New Jersey facility
Will meet the current need for additional cold storage and a larger analytical laboratory
Finance
Meda to acquire Rottapharm for around €3bn in cash and shares
Expanding its business in consumer healthcare products and in emerging markets
Finance
Meda to acquire Acton Pharmaceuticals for US$135m
Transaction includes the Aerospan inhaler for the treatment of asthma
Research & Development
Meda expands collaboration with Cipla
Expands its exclusive rights to allergic rhinitis treatment Dymista
Subscribe now